Gritstone bio Inc
Change company Symbol lookup
Select an option...
GRTS Gritstone bio Inc
QTWO Q2 Holdings Inc
DNAB Social Capital Suvretta Holdings Corp II
UPST Upstart Holdings Inc
GILT Gilat Satellite Networks Ltd
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
OXBR Oxbridge Re Holdings Ltd
NVO Novo Nordisk A/S
JNJ Johnson & Johnson

Health Care : Biotechnology | Small Cap Value
Company profile

Gritstone bio, Inc. is a biotechnology company. The Company discover, develop, manufacture and deliver next generation cancer and infectious disease immunotherapy candidates by vaccine vectors, self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. The Company has an infectious disease pipeline, which includes two programs in clinical-stage development: CORAL, a second-generation COVID-19 vaccine program that may have pan-coronavirus potential to protect against future coronavirus pandemics, and an HIV therapeutic/cure vaccine candidate that are collaborating on with Gilead Sciences, Inc. The Company’s product candidates include GRT-C907 (ChAd)/R908 (samRNA), GRT- C909 (ChAd)/R910 (samRNA), GRT-C909 (ChAd)/R910 (samRNA), GRT-R914 (samRNA), GRT-R912 (samRNA) and GRT-R918 (samRNA).

Closing Price
Day's Change
0.04 (1.58%)
B/A Size
Day's High
Day's Low

10-day average volume:

LifePoint Health Partners with Health Catalyst to Advance Patient Care

9:00 am ET July 27, 2022 (PR Newswire) Print

Health system leverages innovative data and analytics technology to further drive improvements in quality and patient safety in communities nationwide

Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with LifePoint Health, a diversified healthcare delivery network that operates 63 community hospital campuses, more than 30 rehabilitation and behavioral health hospitals, and 170 additional sites of care from coast to coast.

The partnership will leverage Health Catalyst's robust technology and solutions to help reduce variation in clinical outcomes for patients, improve the overall quality of care, and further advance LifePoint's data and analytics capabilities to support its award-winning National Quality Program. It also further strengthens and builds upon LifePoint's strategy for driving innovation, called "LifePoint Forward." LifePoint Forward represents existing and new capabilities to identify, invest in and deploy solutions to improve quality, access and patient outcomes while lowering costs.

"Partnering with Health Catalyst will enable us to better leverage important clinical data that can drive meaningful improvements in patient care, safety and satisfaction while advancing our mission of Making Communities Healthier," said Christopher Rehm, MD, senior vice president and chief medical officer of LifePoint Health. "We are committed to taking a data-driven approach to improving care delivery through our National Quality Program and look forward to the many ways our collaboration with Health Catalyst will help support and accelerate this critical work."

LifePoint Health has selected the Health Catalyst Data Operating System (DOS(TM)) platform, Pop Analyzer(TM), Pop Insights(TM), Healthcare.AI(TM), Patient Safety Monitor(TM), MeasureAble(TM), Instant Data Entry Application (IDEA), and Analytics Accelerators. Together, these technologies and solutions will empower LifePoint Health to discover and share performance insights with self-service dashboards, enable self-service data science within business intelligence (BI), improve quality measurement and reporting, and ultimately, make better clinical, operational, and financial decisions, among other benefits.

"We have great admiration for LifePoint Health and are honored to have the opportunity to support the organization's efforts to improve quality and safety as a leader in community-based care," said Dan Burton, CEO of Health Catalyst. "The Health Catalyst DOS platform, along with our technology product suites and applications, and improvement expertise, will best position LifePoint Health to achieve, sustain, and scale the highest standards of care across its network."

About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform--powered by data from more than 100 million patient records and encompassing trillions of facts--as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

About LifePoint HealthLifePoint Health is a leading healthcare provider that serves patients, clinicians, communities and partner organizations across the healthcare continuum. Driven by a mission of Making Communities Healthier(R), the company has a growing diversified healthcare delivery network comprised of more than 50,000 dedicated employees, 63 community hospital campuses, more than 30 rehabilitation and behavioral health hospitals and 170 additional sites of care, including managed acute rehabilitation units, outpatient centers and post-acute care facilities. Through its innovation strategy, LifePoint Forward, the company is developing meaningful solutions to enhance quality, increase access to care, and improve value across the LifePoint footprint and communities across the country. For more information, visit

Media Contacts:Tarah Neujahr BryanChief Brand and Communications

Logan SimmonsAssistant Vice President, CommunicationsLifePoint

View original content to download multimedia:

SOURCE Health Catalyst

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.